npj Parkinson's Disease

Journal

Publication Venue For

  • Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study.  7. 2021
  • Exploring human-genome gut-microbiome interaction in Parkinson’s disease.  7. 2021
  • Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins.  7. 2021
  • Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease.  7. 2021
  • The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism.  7. 2021
  • COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside.  6. 2020
  • Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.  6. 2020
  • Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20.  6. 2020
  • Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens..  6:11. 2020
  • PINK1 phosphorylates ubiquitin predominantly in astrocytes..  5:29. 2019
  • Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.  5. 2019
  • PINK1 phosphorylates ubiquitin predominantly in astrocytes.  5. 2019
  • Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics.  4. 2018
  • Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.  3. 2017
  • The Gordon Research Seminar & Conference on Parkinson’s disease: state of the Science 200 years after James Parkinson’s essay on the Shaking Palsy.  3. 2017